Literature DB >> 15117839

Independent association between plasma leptin and C-reactive protein in healthy humans.

Abu S M Shamsuzzaman1, Mikolaj Winnicki, Robert Wolk, Anna Svatikova, Bradley G Phillips, Diane E Davison, Peter B Berger, Virend K Somers.   

Abstract

BACKGROUND: C-reactive protein (CRP) is synthesized from the liver and is regulated by cytokines, especially interleukin-6. Leptin, the adipocyte-derived protein product of the ob gene, is related to amount of body fat. The long form of the leptin receptor resembles cytokine receptors, which include the interleukin-6 receptor. Both leptin and CRP may be increased in women, in obesity, and in inflammation, and both have been linked to cardiovascular pathophysiological processes and increased cardiovascular risk. We tested the hypothesis that leptin is associated with CRP levels independently of the influences of gender, body mass index (BMI), waist-to-hip ratio, and other variables. METHODS AND
RESULTS: We studied 100 healthy volunteers (48 men, and 52 women). For all subjects, leptin was independently associated with CRP after adjustment for age, gender, BMI, waist-to-hip ratio, smoking, and alcohol consumption (F=12.39, P=0.0007). There was a strong and significant positive relationship between leptin and CRP in both women (R=0.61, P<0.0001) and men (R=0.55, P<0.0001) considered separately. The association between leptin and CRP was significant even after adjustment for age, BMI, waist-to-hip ratio, smoking, and alcohol consumption in women (F=7.13, P=0.01) and men (F=5.69, P=0.02). When only subjects with BMI <25 kg/m2 were considered (n=47), CRP was not linked to BMI (R=0.02, P=0.96), but a significant association between leptin and CRP was still evident (R=0.55, P<0.0001).
CONCLUSIONS: Leptin and CRP levels are independently associated in normal humans, providing further evidence linking metabolic and inflammatory cardiovascular disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117839     DOI: 10.1161/01.CIR.0000127960.28627.75

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

1.  Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.

Authors:  John R Koethe; Aihua Bian; Ayumi K Shintani; M Sean Boger; Valerie J Mitchell; Husamettin Erdem; Todd Hulgan
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

2.  Role of leptin in autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Siloşi; Suzana Rogoz
Journal:  Maedica (Bucur)       Date:  2013-03

3.  Effects of leptin on cardiovascular physiology.

Authors:  Johnathan D Tune; Robert V Considine
Journal:  J Am Soc Hypertens       Date:  2007 Jul-Aug

4.  Correlates of leptin in children with chronic kidney disease.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2014-07-25       Impact factor: 4.406

5.  C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals.

Authors:  Seth S Martin; Atif N Qasim; Dan J Rader; Muredach P Reilly
Journal:  Obesity (Silver Spring)       Date:  2011-07-07       Impact factor: 5.002

Review 6.  Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

Authors:  Jarrod D Knudson; Gregory A Payne; Léna Borbouse; Johnathan D Tune
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

7.  Workplace based mindfulness practice and inflammation: a randomized trial.

Authors:  William B Malarkey; David Jarjoura; Maryanna Klatt
Journal:  Brain Behav Immun       Date:  2012-10-16       Impact factor: 7.217

8.  Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey.

Authors:  Stephen M Amrock; Michael Weitzman
Journal:  Atherosclerosis       Date:  2014-06-23       Impact factor: 5.162

9.  Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes.

Authors:  C-H Chu; J-K Lee; H-C Lam; C-C Lu; C-C Sun; M-C Wang; M J Chuang; M-C Wei
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

Review 10.  Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.

Authors:  Seth S Martin; Atif Qasim; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.